XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Net Loss Per Share
3 Months Ended
Mar. 31, 2024
Net Loss Per Share [Abstract]  
NET LOSS PER SHARE

Note 8  NET LOSS PER SHARE

 

Shares under the Management Contingent Share Plan that are under review to the former CEO are included in the calculation of net loss per share, as more fully discussed in Note 11. The Company excluded the effect of the 15,001 and 423,700 Management Contingent Shares outstanding and not vested as of March 31, 2024 and 2023, respectively, from the computation of basic and diluted net loss available to common stockholders per share for the three months ended March 31, 2024 and 2023, as the conditions to trigger the vesting of the Management Contingent Plan Shares had not been satisfied as of March 31, 2024 and 2023. The Management Contingent Share Plan is more fully discussed in Note 8 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

 

The following table sets forth the calculation of basic and diluted net loss available to common stockholders per share for the periods presented based on the weighted average number of shares of the Company’s Class A Common Stock outstanding during the three months ended March 31, 2024 and 2023:

 

   2024   2023 
Net loss  $(1,504)  $(7,639)
Deemed dividends related to Assumed Warrants   (656)   
-
 
Net loss to common stockholders  $(2,160)  $(7,639)
Basic and diluted weighted average number of Class A Common Stock (in thousands)
   8,918    2,315 
Basic and diluted net loss available to common stockholders per share
  $(0.24)  $(3.30)

 

The following Class A Common Stock equivalents of the Company have been excluded from the computation of diluted net loss available to common stockholders per share as the effect would be antidilutive (shares in actuals):

 

   March 31,
2024
   March 31,
2023
 
Public and private warrants   1,037,875    1,037,875 
Assumed Warrants   3,315,227    190,585 
Stock options   113,127    227,310 
Finder’s warrants   74,503    
-
 
Total antidilutive shares   4,540,732    1,455,770